Bisphosphonates reduce the overall risk of osteoporotic fractures and have a long-term beneficial effect. However, they reduce bone turnover and allow micro-cracks to accumulate over time, leading to atypical femoral fracture (AFF) \[[@b1-jptm-2020-05-14]\]. There have been many reports of AFF in the subtrochanter or the diaphysis that were attributed to accumulation of tensile stress in these regions \[[@b2-jptm-2020-05-14]\]. According to Koch \[[@b3-jptm-2020-05-14]\], the greatest tensile strength occurs at the superior cortex of the femoral neck. However, to our knowledge, there have been only three cases of atypical femoral neck fracture (AFNF) \[[@b4-jptm-2020-05-14],[@b5-jptm-2020-05-14]\]. In addition, none of those case reports revealed evidence related to suppressed bone turnover rate. Here, we report a case of AFNF with detailed pathological findings and a literature review.

CASE REPORT
===========

A 71-year-old female was referred to our clinic with a 3-month history of pain in the right groin. Her pain was not preceded by a fall or any injury. Three weeks before presenting to our clinic, the pain worsened so that she could not bear weight on the right hip, and she underwent hip radiography and magnetic resonance imaging (MRI) at the referring hospital, where she was conservatively treated for a bone contusion. The patient had been taking 3 mg of intravenous ibandronate sodium every 3 months over the previous 4 years for osteoporosis. At admission, the bone mineral densities (T-score) of the lumbar spine, total hip, and femoral neck were --3.6, --1.4, and −1.2, respectively. On physical examination, there was pain limitation to range of motion and a positive log roll test for the right hip.

Laboratory tests showed normal adjusted serum calcium (8.9 mg/dL; normal range, 8.0 to 10.5), inorganic phosphorus (3.2 mg/dL; normal range, 2.5 to 4.5), serum creatinine (0.7 mg/dL; normal range, 0.6 to 1.1), and alkaline phosphatase (85 IU/L; normal range, 40 to 120). However, 25-hydroxycholecalciferol (17.8 ng/mL; normal range, 30 to 80) and urinary excretion of the N-telopeptide of type I collagen (8 nM bone collagen equivalents/nM creatinine; normal range, 11 to 91) were decreased.

Hip radiograph performed at our hospital upon admission showed a more definite and extended incomplete right femoral neck fracture ([Fig. 1A](#f1-jptm-2020-05-14){ref-type="fig"}, [B](#f1-jptm-2020-05-14){ref-type="fig"}), whereas a 1.5T MRI conducted at the referral hospital had shown a decreased signal intensity without fracture on the right femur neck ([Fig. 1C](#f1-jptm-2020-05-14){ref-type="fig"}).

A specimen that included the fracture line was obtained and stained with hematoxylin and eosin (H&E) ([Fig. 2A](#f2-jptm-2020-05-14){ref-type="fig"}). The fracture gap appeared as a vertical, nearly empty crack, ≤ 0.1 mm wide, and containing mainly amorphous acellular material. No hematoma, vessels, chondrocytes, or inflammatory cells were seen within the fracture gap ([Fig. 2B](#f2-jptm-2020-05-14){ref-type="fig"}). The deep portion of the fracture was mostly replaced by fibrovascular tissue with a focal area of osteoid formation, indicating fracture healing ([Fig. 2C](#f2-jptm-2020-05-14){ref-type="fig"}). Increased remodeling activity (active osteoblastic rimming and osteoclast proliferation) was seen around the fracture gap ([Fig. 2D](#f2-jptm-2020-05-14){ref-type="fig"}). Osteoclasts were widely distributed, except within the fracture gap ([Fig. 2](#f2-jptm-2020-05-14){ref-type="fig"}). There were giant multinucleated osteoclasts, with more than 8 detached from the shallow resorption cavity ([Fig. 3](#f3-jptm-2020-05-14){ref-type="fig"}). The patient was diagnosed with AFNF based on history of long-term bisphosphonate therapy, suppressed bone turnover marker (urinary excretion of the N-telopeptide of type I collagen), and radiologic and pathological findings.

Because the patient required early weight bearing, bipolar arthroplasty was performed rather than internal fixation. Bisphosphonate treatment was discontinued, oral supplemental vitamin D was prescribed, and teriparatide was administered subcutaneously to prevent osteoporotic fracture. The patient was able to bear full weight immediately after the operation, and no pain was felt in either hip at 3 months postoperatively.

DISCUSSION
==========

To our knowledge, only three cases of atypical femoral neck fractures have been previously reported with little evidence. Khan et al. \[[@b5-jptm-2020-05-14]\] reported the pathological findings of disconnected, mainly thin trabecular bone with necrosis, hemorrhaging, and acute inflammatory cells. However, these pathological findings are not specific to AFF and are considered evidence of acute fracture in osteoporotic patients \[[@b6-jptm-2020-05-14],[@b7-jptm-2020-05-14]\]. However, the pathology from the present case showed that the fracture gap contained amorphous acellular material and no living cells. Conversely, the adjacent bone revealed living cells, including active osteoclasts. These findings show that the present case was not an acute fracture, but a stress fracture.

Osteoclasts normally contain up to eight nuclei before apoptosis, but in the present case, there were giant multinucleated osteoclasts with more than 8 nuclei detached from the shallow or absent resorption cavity. This is as a characteristic finding of bisphosphonate-related atypical fractures \[[@b8-jptm-2020-05-14]-[@b10-jptm-2020-05-14]\]. Osteoclast apoptosis is likely due to exposure to a high extracellular concentration of calcium released during bone absorption \[[@b11-jptm-2020-05-14],[@b12-jptm-2020-05-14]\]. Bisphosphonate inhibits formation of the guanosine triphosphate-binding protein necessary for osteoclasts to form the ruffled border necessary for adhesion and resorption on bone surface; therefore, calcium concentration in the resorption cavity does not increase due to loss of absorption from long-term bisphosphonate use \[[@b13-jptm-2020-05-14]\]. As a result, by reducing the signal (high extracellular calcium concentration), which is important for osteoclast apoptosis, the lifespan of the osteoclast increases; therefore, the number of osteoclasts does not decrease, and fusion continues to form giant multinuclear cells \[[@b8-jptm-2020-05-14],[@b14-jptm-2020-05-14]\]. Giant multinuclear cells are also found in Paget's disease, secondary hyperparathyroidism, giant cell tumor, and fibrodysplasia. However, these conditions can be pathologically differentiated by number, size, and apoptosis of osteoclasts; amount of osteoids; and condition of the hematopoietic bone marrow.

Fractures originating in the femoral neck and in the intertrochanteric femur are excluded from the case definition of AFF because they are more likely to be associated with other causes such as trauma or osteoporosis. However, given that atypical fractures are clustered at the region of maximal tensile loading, the superior cortex of the femoral neck withstands maximum tensile stress, putting it at risk of atypical fractures \[[@b2-jptm-2020-05-14],[@b3-jptm-2020-05-14]\]. We assumed that the paucity of reports on AFNFs was related to the fractures being mistaken for the transverse type of osteoporotic insufficiency fractures \[[@b15-jptm-2020-05-14]\]. In osteoporosis, the pathology shows thin trabeculae disconnected from each other, enlarged areolar tissue, and increased resorption cavity, and the increased bone turnover marker is shown in laboratory testing. In the present case, urinary excretion of the N-telopeptide of type I collagen was reduced, reflecting a decrease in bone remodeling due to bisphosphonate \[[@b16-jptm-2020-05-14],[@b17-jptm-2020-05-14]\]. Recently, atypical fractures were also reported in the ulna, tibia, ilium, and pubis \[[@b18-jptm-2020-05-14]-[@b20-jptm-2020-05-14]\]. Therefore, I propose that the case definition of AFF be limited to femoral subtrochanter and shaft that require supplementation.

There is a limitation in this study. Histomorphometry of giant multinuclear osteoclasts (i.e., scale, shape, and position) and number of giant multinuclear osteoclasts were not detailed, as only H&E staining was performed.

In conclusion, the patient in the present case had no trauma history, long-term bisphosphonate use, reduced urinary excretion of the N-telopeptide of type I collagen, and a pathological finding of bisphosphonate-related atypical fracture comprised of amorphous acellular material and no living cells in the fracture gap and giant multinucleated osteoclast detached from the bone perimeter. For patients with groin pain with minimal or no trauma and a history of prolonged bisphosphonate use, the possibility of AFNF should be considered.
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Thanks to Change-jin Kim and Pan-jo Kim, who assisted me in finding giant multi-nucleated cells in a cold pathology room.

![(A) A radiograph performed 3 weeks before referral to our hospital shows a minimal fracture line (white arrow) on the superior cortex of the right femoral neck. (B) A radiograph performed at our hospital at admission shows a more definite and nearly vertical radiolucent line (fracture) in the right femoral neck. (C) T1 magnetic resonance imaging shows a decreased signal intensity in the superior and central aspect of the right femoral neck, which represents bone marrow edema.](jptm-2020-05-14f1){#f1-jptm-2020-05-14}

![(A) Specimen shows a definite incomplete fracture of the superior femoral neck (arrow). (B) A thin fracture line (arrows) extends through the entire thickness of the cortex. (C) A thin fracture gap contained amorphous acellular material (asterisk) but no hematoma, vessels, chondrocytes, or inflammatory cells. However, remodeling cavities with increased cellular activity are seen in the bone adjacent to the fracture gap (arrows). (D) A deep portion of the fracture site is mostly replaced by fibrovascular tissue with a focal area of osteoid formation representing the fracture-healing process (magnification of square area of B).](jptm-2020-05-14f2){#f2-jptm-2020-05-14}

![A giant multinucleated osteoclast with more than 8 nuclei detached from the shallow resorption cavity.](jptm-2020-05-14f3){#f3-jptm-2020-05-14}
